Amphastar Pharmaceuticals, Inc. — Director's Dealing 2018

Jun 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2018-06-14

Reporting Person: Liawatidewi Yakob (SVP Corp Admin Center)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-14	Common Stock	A	1474	—	Acquired	40763	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-14	Stock Option (right to buy)	$16.96	A	3319	Acquired	2028-06-14	Common Stock (3319)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10369	Indirect

Footnotes

F1: The reported shares are represented by restricted stock units, or RSUs, which vest in four equal annual installments beginning on June 14, 2019.

F2: The reported shares are held of record by the Yakob and Sunmoon Family Trust dated July 25, 2013 for which the reporting person serves as a trustee.

F3: Shares subject to the option vest in four equal annual installments beginning on June 14, 2019.